News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|November 7, 2023

Treatment Options for Patients With Primary or Recurrent Cervical Cancer

Author(s)Claire Friedman, MD, Emily Davan, RN, Linda Ryan

Experts on cervical cancer discuss treatment options for patients with primary or recurrent cervical cancer and review the GOG 240 study.

Episodes in this series

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 1 Overview of Cervical Cancer

Linda Ryan, a patient advocate

EP. 2 Cervical Cancer: The Patient Journey

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 3 Patient Perceptions of Cervical Cancer Screening

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 4 Treatment Options for Patients With Primary or Recurrent Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 5 Treatments for Patients With Newly Diagnosed Metastatic Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 6 Individualized Treatment Selection in Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 7 Tisotumab Vedotin for Patients With Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 8 Unmet Needs in the Cervical Cancer Treatment Landscape

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 9 Shared Decision-Making in Cervical Cancer

Linda Ryan, a patient advocate

EP. 10 Cervical Cancer: Advocating for Yourself and Communicating With Family

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 11 Cervical Cancer: Insight into the Patient Experience

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 12 Myths Around Cervical Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of uterus.

Camrelizumab Combo Extends Survival in Metastatic Cervical Cancer

October 20th 2025

Patient Perspectives on Learning About Their HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Expert Overview of Recurrent/Metastatic HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Final Thoughts and Hope for a Cure

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Future Perspectives in Multiple Myeloma

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Trending on CURE

What to Know About the FDA Approval of Blenrep for Multiple Myeloma

FDA Grants Exousia Pro Orphan Drug Designation in Glioma

Sharing Insights Into a Multiple Myeloma Journey

With Cancer, 'Your Outlook Will be Significant in Beating this Disease'

Advancing Research Offers Hope for Patients With Liver Cancer

© 2025 MJH Life Sciences^®

All rights reserved.